Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* age \>= 18 years~* written informed consent~Group A - patients with thermal burns~* partial thickness burns (2nd degree) requiring non-surgical primary treatment~* primarily 5-15% TBSA burns, but burn patients with injury size from 1 to 40% TBSA may be included~or~Group B - patients with thermal burns~* non-grafted partial thickness burns (2nd degree) in patients requiring autotransplantation in the early phase~* primarily 5-15% TBSA burns, but burn patients with injury size from 1 to 40% TBSA may be included~or~Group C - patients with thermal burns~* donor site(s) on the ventral side of the body and limbs in deep partial thickness burns (2nd degree) and/or full thickness burns patients requiring autotransplantation during the first 1-3 weeks after injury~* primarily 5-15% TBSA burns, but burn patients with injury size from 1 to 40% TBSA may be included~Exclusion Criteria:~* inhalation injury to airways and lungs~* chemical or high voltage electrical burn~* pregnancy, lactation~* clinical signs or symptoms of acute infection~* any prescription or non-prescription topical medication administered within one week prior to study start~* hematological and clinical/chemical parameteres judged as unacceptable by the investigator~* donor sites with re-harvesting~* previous treatment with soluble beta-1,3/1,6-glucan~* participation in other clinical studies in the last 4 weeks

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).